Detalles de la búsqueda
1.
Immunogenicity and safety of Mebella™ vaccine developed by Human Biologicals Institute in a Phase II/III, randomized, multicentric, non-inferiority study.
Vaccine
; 41(44): 6558-6564, 2023 Oct 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37659893
2.
Immunogenicity and safety of HavisureTM vaccine developed by Human Biologicals Institute in healthy subjects of 12 months to 49 years of age: A phase II/III, randomized, single blind, non-inferiority study.
Vaccine
; 41(42): 6215-6220, 2023 10 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37661535
3.
Safety and immunogenicity of inactivated hepatitis-A vaccine developed by Human Biologicals Institute in two age groups of healthy subjects: A phase I open label study.
Vaccine
; 39(15): 2088-2093, 2021 04 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33741190
Resultados
1 -
3
de 3
1
Próxima >
>>